Brazil’s CNI puts faster product approvals among priorities for regulatory reform
This article was originally published in Clinica
Executive Summary
Brazil’s pan-industrial confederation, CNI, has called on regulatory agency Anvisa to simplify healthcare product regulation and hasten the product approvals process, in a move to support the interests of both the medtech and pharma sectors.